|
Accession number;02A0476596
|
| Title;Pharmacologic treatment of Patients with Low Levels of High-Density Lipoprotein. |
| Author;
KOTAKE HIDETOSHI
(Tohokudai I Tonyobyotaishaka)
OIKAWA SHIN'ICHI
(Nippon Med. Sch.)
|
Journal Title;Prog Med
|
Journal Code:F0664B
|
ISSN:0287-3648
|
|
VOL.22;NO.4;PAGE.983-987(2002)
|
| Figure&Table&Reference;FIG.2, TBL.1, REF.11 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;Low levels of high-density lipoprotein(HDL-C) constitute a strong risk factor for developing coronary heart disease. This risk can be decreased by even slight improvements in HDL-C levels. A growing number of trials that used fibrates, niacin, thiazolidinediones and statin alone or in combination with other lipid-altering agents have shown that these drugs are effective for reducing total cholesterol, low-density lipoprotein cholesterol(LDL-C) and triglycerides, and for increasing high-density lipoprotein cholesterol(HDL-C) levels. (author abst.) |
|
|
|
Related Articles;
|
